Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Methyl 1-[2-chloro-4-(1-pyrrolidinyl)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-5-acetate | HCID 11102003 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | HCID 11811713 | HCID 11811713 | 80.2% |
Reaction Steps
5-Methoxycarbonylmethyl-1-[4-(1-pyrrolidinyl)-2-chlorobenzoyl]-2,3,4,5-tetrahydro-1H-benzazepine (183 g) is suspended in methanol (2 liters), and thereto is added a 5N sodium hydroxide (171 ml), and the mixture is stirred at 60° C. for four hours. To the mixture is added a 5N sodium hydroxide (60 ml), and the mixture is stirred at 70° C. for one hour. The mixture is acidified with hydrochloric acid, and concentrated under reduced pressure to remove the methanol. The crystals are collected by filtration, washed with water, and dried to give 5-carboxymethyl-1-[4-(1-pyrrolidinyl)-2-chlorobenzoyl]-2,3,4,5-tetrahydro-1H-benzazepine (142 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06096736 |
|---|
| Source dataset | uspto-grants-2000_08 |
|---|
| ORD ID | ord-d421784bff0d4d558f0b52a8dd45f592 |
|---|
| Source note | uspto-grants-2000_08 |
|---|